These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31300371)

  • 1. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis.
    Cheng Y; Chen Y; Zhou C; Shen L; Tu F; Xu J; Liu C
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):73-81. PubMed ID: 31300371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
    Meng F; Song L; Wang W
    J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
    Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
    Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
    He XK; Su TT; Si JM; Sun LM
    Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.
    Mei ZB; Zhang ZJ; Liu CY; Liu Y; Cui A; Liang ZL; Wang GH; Cui L
    PLoS One; 2014; 9(3):e91818. PubMed ID: 24647047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
    Nie Z; Zhu H; Gu M
    Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis.
    Shuai Y; Li C; Zhou X
    Clin Transl Oncol; 2020 Sep; 22(9):1580-1590. PubMed ID: 32060719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis.
    Wang Q; Shi M
    Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin may improve the prognosis of patients with pancreatic cancer.
    Zhang JW; Sun Q
    Asian Pac J Cancer Prev; 2015; 16(9):3937-40. PubMed ID: 25987064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metformin on the mortality of colorectal cancer patients with T2DM: meta-analysis of sex differences.
    Wang Y; Xiao J; Zhao Y; Du S; Du J
    Int J Colorectal Dis; 2020 May; 35(5):827-835. PubMed ID: 32100113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus increases the risk of colorectal neoplasia: An updated meta-analysis.
    Luo S; Li JY; Zhao LN; Yu T; Zhong W; Xia ZS; Shan TD; Ouyang H; Yang HS; Chen QK
    Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):110-23. PubMed ID: 26162991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between metformin therapy and risk of colorectal cancer in patients with diabetes mellitus: a meta-analysis.
    Yang WT; Yang HJ; Zhou JG; Liu JL
    Int J Colorectal Dis; 2020 Nov; 35(11):2117-2131. PubMed ID: 32720184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis.
    Zhang ZJ; Li S
    Diabetes Obes Metab; 2014 Aug; 16(8):707-10. PubMed ID: 24460896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis.
    Zhang ZJ; Zheng ZJ; Kan H; Song Y; Cui W; Zhao G; Kip KE
    Diabetes Care; 2011 Oct; 34(10):2323-8. PubMed ID: 21949223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of Colorectal Cancer Patients With Diabetes Mellitus: A Meta-Analysis.
    Petrelli F; Ghidini M; Rausa E; Ghidini A; Cabiddu M; Borgonovo K; Ghilardi M; Parati MC; Pietrantonio F; Sganzerla P; Bossi AC
    Can J Diabetes; 2021 Mar; 45(2):186-197.e2. PubMed ID: 33039329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis.
    Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL
    Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus.
    Tarhini Z; Manceur K; Magne J; Mathonnet M; Jost J; Christou N
    Sci Rep; 2022 Jul; 12(1):12374. PubMed ID: 35859114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monotherapy with Metformin versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.
    Mekuria AN; Ayele Y; Tola A; Mishore KM
    J Diabetes Res; 2019; 2019():7676909. PubMed ID: 31828167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
    Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D
    Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta-analysis.
    Xin WX; Fang L; Fang QL; Zheng XW; Ding HY; Huang P
    Medicine (Baltimore); 2018 Mar; 97(9):e0035. PubMed ID: 29489653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.